Kabra Drugs Limited (BOM:524322)
27.17
+0.19 (0.70%)
At close: Jan 22, 2026
Kabra Drugs Market Cap
Kabra Drugs has a market cap or net worth of 644.14 million as of January 23, 2026. Its market cap has increased by 2,613.05% in one year.
Market Cap
644.14M
Enterprise Value
531.85M
Revenue
269.14M
Ranking
n/a
PE Ratio
43.79
Stock Price
27.17
Market Cap Chart
Since May 17, 2001, Kabra Drugs's market cap has increased from 7.46M to 644.14M, an increase of 8,533.90%. That is a compound annual growth rate of 19.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 644.14M | -11.06% |
| Dec 31, 2025 | 724.27M | 614.30% |
| Dec 30, 2024 | 101.40M | 328.65% |
| Dec 26, 2023 | 23.65M | 21.67% |
| Dec 30, 2022 | 19.44M | -11.40% |
| Dec 27, 2021 | 21.94M | 15.21% |
| Dec 28, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Reliance Industries | 19.13T |
| HDFC Bank | 14.28T |
| Bharti Airtel | 12.07T |
| Tata Consultancy Services | 11.45T |
| ICICI Bank | 9.87T |
| State Bank of India | 9.59T |
| Infosys | 6.80T |
| Hindustan Unilever | 6.24T |